In a statement, the company explained that elevated vitamin D can cause vomiting, loss of appetite, increased thirst, increased urination, excessive drooling, and weight loss. At high levels, it can lead to serious health issues in dogs including renal dysfunction.
The company is inviting 'pet parents' (dear god, spare me) whose dogs are suffering symptoms after eating the products to contact their veterinary surgeon.
Hill's also says it will cover the cost of testing total calcium, albumin and 25OH-Vitamin D3 metabolites in animals which have consumed affected products, at the VitDAL Lab at the Edinburgh Veterinary School.
The affected products are:
Vetoquinol has announced the launch of Enisyl-FTM, the first L-Lysine supplement developed for veterinary use in the UK and Ireland.
Vetoquinol says a unique distributing pump and paste formulation will aid compliance in cats that require L-Lysine supplementation and make administration of L-Lysine much easier. Each pump action delivers 1ml of Enisyl-F paste at each press, which can be applied directly into the cat's mouth or on the paw to be licked off. It can also be added to food.
Zorica Agbaba, Enisyl-F's Product manager said: "We are delighted to have launched Enisyl-F and I am sure it will prove very useful to veterinary surgeons, especially when it comes to aiding compliance in cats that require L-Lysine supplementation."
To try Enisyl-F or for more information about the product, contact your local Vetoquinol representative or call Vetoquinol main office on 01280 814 500 (UK) or 1800 406 117 (ROI free phone number). Alternatively visit http://www.vetoquinol.co.uk/ website.
The practice is one of few in the UK to use radioactive iodine (RAI) therapy, which, it says, has an average, a 95% success rate in treating cats with hyperthyroidism.
Stephanie Lalor MRCVS (pictured right), an RCVS Specialist in Feline Medicine at Willows said: "The new therapy is non-invasive and is the gold standard of treatment for cats with hyperthyroidism. It is safe and highly effective and a single injection can be curative. Patients do need to be screened for their suitability and ideally they are treated with medical therapy prior to the RAI.
"Due to the radioactive nature of the treatment, patients must stay with us for 15 days after the injection. Our patients stay in luxury cat condos during their hospitalisation and their day-to-day care is over-seen by our lead radioactive iodine nurse, Vicky Maund."
The new unit is part of a £1 million investment in Willows which includes a dedicated operating theatre for minimally invasive procedures, a range of specialist treatment rooms and more than 40 new kennels.
Toby Gemmill, clinical director at Willows, said: "We are already extremely well placed to offer a wide variety of specialist treatments and this extension has provided us with the space to expand our services further. The new radioactive iodine unit is very exciting and allows us to build on our gold level cat-friendly clinic status."
For more information, visit www.willows.uk.net.
The 'Room For Rabbits' campaign follows research in which 38% of vets said they think rabbits’ environment is the most neglected welfare need1, with over a quarter of the UK’s rabbits being kept in inadequate housing conditions, and almost half of them living alone2.
The RAW survey also found that 90% of vets believe that rabbits’ welfare in the UK is improving3.
Room for Rabbits will throw a spotlight on rabbits’ environment, with a variety of initiatives during RAW including vet blogs and videos on how to adapt bunnies’ housing for all seasons, boredom buster ideas, a competition to encourage owners to create a RAW ‘gold standard’ environment, and downloadable packs containing resources for practices to create their own RAW campaigns.
Holly Castle, Senior Brand Manager at Burgess Pet Care, RAAG member and organisers of RAW, said: “We are delighted that RAW continues to have a positive impact, with our survey showing that 90% of vets believe that the welfare of the UK’s rabbits is improving - but there is always more than we can do.
“Since the previous RAW campaign, we have successfully launched RAAG, which recognises that the welfare of these wonderful creatures needs to be high on the agenda year-round.
"By bringing together the expertise of the RAW partners, RAAG is focused on encouraging everyone involved with rabbits to support the first Good Practice Code for rabbits’ welfare in England to ensure it becomes enshrined in law.
"One of the ways to achieve this is through initiatives like RAW, which is the UK’s largest welfare campaign of its kind.
“We recognise that vets’ practices were really stretched last year due to the Covid-19 pandemic, which meant it was difficult to support campaigns like RAW.
"However, following a surge in demand for rabbit ownership in the UK during the past two years, it is vitally important that we educate more owners than ever before and continue to help improve rabbits’ welfare."
“The veterinary community plays a hugely important role in ensuring that owners have access to the right information, and we are urging practices to throw their support behind this year’s RAW to ensure that we reach as many owners as possible.
Professor Ian Ramsey, Past President of the BSAVA, which endorses RAW, said: "The BSAVA is once again delighted to support RAW and the theme of this year’s campaign.
"Rabbits remain one of the most misunderstood pets in the UK, but we are confident that vets across the UK will again show their support for this important campaign to improve the lives of pet rabbits.”
The RAAG is encouraging vets’ practices to sign up to receive updates about RAW at https://www.rabbitawarenessactiongroup.co.uk/raw-pack-reminder/.
Downloadable RAW vet packs will also be available from 6th June.
The newly refurbished and extended HQ at Woodrow House in Gloucestershire includes a practical wetlab equipped to share learning with a remote audience, hi-tech lecture rooms and a second teaching room where equipment such as microscopes or X-ray screens can be used.
Meeting rooms include video conferencing technology and giant presentation screens, and there are modern working environments, energy-saving innovations and pleasant break-out areas, all designed to make the building more inspiring, welcoming and comfortable.
Outside there are electric car charge points, bicycle racks and a landscaped area for wildlife with five bird boxes, a small pond and a log pile.
The two-year transformation was unveiled today with an opening address by Lord Trees (pictured right, on the right with Phil Lhermette), who said: "The BSAVA has always been a very dynamic and innovative organisation and this development is the latest example.
"Following their mission to pursue excellence in small animal practice through education and science, the wonderful facilities of this new building will provide a great resource for veterinary education and CPD which of course not only benefits vets and vet nurses but more importantly will ultimately benefit the health and welfare of our pet population.
"The building offers the very latest facilities to deliver high quality teaching and learning and has the capacity to be expanded as necessity dictates. I’m delighted to see the BSAVA investing in the future of the profession and this building, and the online technology it houses including the new digital library, will enable the organisation to continue to deliver its mission well into the future."
BSAVA President Phil Lhermette said: "Over the past 60 years BSAVA has put science and education at the heart of our organisation, and our successful growth includes delivering high quality CPD in an exciting new environment, which will be perfect for everyone to learn in the most conducive way.
"It has been 20 years since we moved into Woodrow House, so it was time for a one-off, ethical transition to create a modern, fit-for-purpose facility for all our members to enjoy."
BSAVA Head of Education Lucie Goodwin said: "These state-of-the-art, scientific-based education facilities will support highly valued, practical CPD for all veterinary professionals, and disseminate learning to a remote audience through video technologies in the classroom - a model that is poised to accelerate because of the proliferation of portable devices and the explosion of mobile phone capabilities."
A paper introduced by the RCVS Registrar Eleanor Ferguson looked at the possibility of the RCVS prosecuting, for example, unqualified individuals undertaking veterinary work and courses falsely purporting to lead to a registerable qualification.
The paper also explored other options, including better educating animal owners about veterinary services and assisting people with concerns about the breaches of the VSA to raise them with the authorities.
Council heard that over the past year, the RCVS had assisted other agencies on investigations of suspected VSA breaches on a number of occasions.
It was considered that the RCVS could consider undertaking its own private investigations and criminal prosecutions when statutory prosecuting authorities did not have the resources to pursue these cases.
However, the RCVS has no statutory powers of investigation, so if it did pursue a private prosecution, it would have no powers to carry out a criminal investigation or compel evidence.
Council members voted for a further paper setting out a draft policy on private prosecutions, as well as what general information regarding breaches of the Veterinary Surgeons Act could be provided to members of the public and the professions.
Eurovet Animal Health has launched a new product, Bovocycline 2000 mg pessary for cattle.
Bovocycline 2000 is the only veterinary licenced antibiotic pessary for the treatment of retained foetal membranes in cattle. It is licenced for the treatment of post parturient disorders in cattle, for administration after dystocia, retained foetal membranes (RFMs) and endometritis.
According to Eurovet, the incidence of retained foetal membranes in cows varies from zero to 25 per cent, but the average is around 4 per cent in most herds. RFMs result in reduced cow fertility and a higher risk of culling due to poor fertility. Pessaries are still considered the preferred treatment for vulval discharges in cattle by farmers.
Ruth Vernon, Technical Services Manager for Eurovet said: "The control of post partum problems in cattle is rarely straight forward, but it is great to have a veterinary licensed treatment designed specifically for this purpose, in one pessary that contains 2000mgs tetracycline".
For more information please contact Eurovet Animal Health. Tel: 01223 257933. E-mail: office@eurovet-ah.co.uk www.eurovet-ah.co.uk
Equibactin vet contains sulfadiazine and trimethoprim, and is indicated for use in the treatment of infections, particularly respiratory tract infections associated with Streptococcus spp. and Staphylococcus aureus; gastrointestinal infections associated with E. coli; urogenital infections associated with beta-hemolytic streptococci; and wound infections and open or drained abscesses associated with Streptococcus spp. and Staphylococcus aureus.
The new product has been designed to provide accurate administration to all sizes of horses or ponies. One syringe provides a complete dose for 600kg bodyweight and is subdivided into 12 markings, to help keep track of dosages.
Dechra Brand Manager Emma Jennings said: "Equibactin vet has a proven antibiotic combination with a synergistic effect2 making it an excellent first line broad spectrum antimicrobial treatment for most Gram positive and negative aerobes.
It can be administered without food which improves the oral bioavailability, offering equine veterinary surgeons a quick and efficient treatment when it comes to targeting these infections that are often experienced in day-to-day practice.
"With its ease of use and three-year shelf life, we anticipate that Equibactin vet will quickly become a popular product when it comes to maintaining equine health."
For more information, visit www.dechra.co.uk/products/equine.
References
The first is that the College will allow veterinary surgeons and nurses to carry over some of the CPD hours they have accrued in 2019 into 2020, to smoothen the transition to an annual hourly requirement.
Vets will be allowed to carry over 25 hours and VNs 10 hours of accumulated CPD from 2019 through to 2020.
This will apply once, in 2020 only, and is only applicable to vets and VNs who have been CPD-compliant from 2017 to 2019 and have a surplus number of hours to carry over.
Secondly, the College is going to allow vets and VNs to take a six-month 'CPD pause' for planned periods away from work, such as parental leave, and exceptional circumstances, such as serious ill health or unforeseen changes to family responsibilities, without the need to make up the hours when they return to work. This will reduce the burden on vets and VNs returning to work after a break.
RCVS Director of Education, Dr Linda Prescott-Clements said: "We hope that these changes to the CPD policy will support vets and VNs to make the transition to an annual hourly requirement.
"We received a sample of feedback from some members of the veterinary professions regarding the move to annual hourly CPD requirements and these additions have been introduced support members during this transition and to mitigate some of the concerns raised."
For more information about the CPD requirement for both vets and vet nurses, what activities might count as CPD, how to record your CPD and a series of frequently asked questions about CPD please visit our dedicated page: www.rcvs.org.uk/cpd.
The new product contains a combination of Omega-3s, toxin binders and antioxidants which the company claims flush out toxins, aid blood flow to the kidneys and maintain kidney architecture.
Matthew Shaw, Managing Director of nutravet said: "We’re really excited to launch nutraren, it’s a product our team have been working on for some time to make sure we have developed the best renal product for vets to recommend to their clients.
"Using independent trial data, we’ve been able to develop a unique formulation for nutraren containing 100% natural ingredients to benefit a pet’s long-term kidney health."
Authorised veterinary practices can now order nutraren from nutravet.
For more information, contact nutravet on 0845 604 1688, visit: www.nutravet.co.uk or email: info@nutravet.co.uk.
The trial, which was conducted by a UK-French team of researchers from PBD Biotech and Biosellal, is being presented at the European Association of Veterinary Laboratory Diagnosticians (EAVLD) Congress in Brussels today.
Current tests only allow the reliable detection of Mycobacterium avium subspecies paratuberculosis (MAP) from 18-24 month calves and are unable to distinguish between active and passive infection.
For the 16-month trial, calves from three different herds and born from MAP-positive and MAP-negative cows were tested monthly using PBD Biotech’s Actiphage Rapid kit and Biosellal’s Bio-T kit MAP PCR on blood samples, and the same PCR on faeces.
Researchers say the trial proves that early detection of live MAP infection is possible, and paves the way for improved Johne’s disease monitoring and control measures on farms.
Co-Author Dr Ben Swift, Research Fellow in Antimicrobial Resistance at the Royal Veterinary College and R&D Director at PBD Biotech, said: "Young animals are highly susceptible to infection and being able to identify Johne’s disease at this early stage is key to controlling disease spread.
The trial showed that the sensitivity and specificity of Actiphage enables detection of lower levels of MAP than the current culture methods, and provides results in 6 hours rather than weeks."
The Actiphage Rapid technology used in the trial identified live MAP infection at least 4 weeks’ earlier than the faecal PCR in 75% of cases: in one case, the new diagnostic detected MAP in the blood of a one-day old calf born from a MAP-positive cow.
Claire Pelletier, Directrice Générale of BioDev, consultant to Biosellal, will be presenting findings from the trial, which also showed the transient nature of the infection. She said: "The study showed that two calves, identified as MAP-positive by Actiphage-PCR on blood during the first monthly sampling didn’t shed MAP into their faeces until 10 and 11 months. This emphasises that early detection provides a short window of time that allow for control of the disease."
Other international trials using Actiphage are underway to investigate the presence of MAP in milk.
The app, which has been accredited by the Association of Veterinary Anaesthetists, contains information about 36 different drug molecules in 10 different drug classes, including analgesics (NSAIDs, opioids and local anaesthetics), sedatives (acepromazine, alpha-2 agonists and benzodiazepines), induction agents, volatile agents, neuromuscular blocking agents, anti-cholinergics, sympathomimetics and antagonists where applicable.
It also offers 24 different dog and 15 cat anaesthetic protocols for procedures carried out in general practice. Each contains information on specific anaesthetic considerations for that condition or patient, any preoperative stabilisation required, premedication, perioperative analgesia, induction, maintenance and recovery.
Additional features include a dose calculator, summary sheets that can be saved or emailed to be attached to the patient’s clinical notes, and the option to save favourite protocols for repeated use.
The app was developed with the advice of two diplomat anaesthetists, Matthew Gurney BVSc CertVA PgCertVBM DipECVAA MRCVS and Joost Uilenreef DVM MVR DipECVAA, together with Elizabeth Barker BVetMed(Hons) Cert AVP(VA) PgCert MRCVS at Dechra.
Dechra Brand Manager Claire Morgan said: "We are passionate about anaesthesia and the provision of excellent support for vets, nurses and students. The app can be used to build confidence and knowledge in less familiar procedures or to update protocols to ensure best anaesthetic practice for the more common routine procedures.
"All of the protocols and information particularly emphasise considerations around anaesthesia, patient monitoring and perioperative analgesia, including local and regional techniques."
She added: "We hope the app will help practitioners to move away from a ‘one protocol fits all’ approach and give them the confidence to tailor the protocols and medications chosen to the specific patient and condition they are treating and to generally improve the standard of anaesthesia and analgesia in small animal practice."
The Dechra Dog and Cat Anaesthesia App is available to download for iOS and Android devices. For more information, visit www.dechra.com/dcaa
The University of Liverpool has developed a new diagnostic tool to help practitioners with their treatment programmes for osteoarthritis in dogs.
VetSurgeon.org member Dr Ben Walton, from the University's School of Veterinary Science, said: "In first opinion and referral practices canine mobility is assessed in a subjective fashion, either by a vet or owner. Assessment can differ between vets, and if more than one limb is affected it becomes even more difficult.
"Pain and mobility associated with this condition depends on recent activity levels, medication and even weather conditions, which mean that a dog can have good and bad periods and any physical assessment will only provide a snapshot of the disease.
"The most reliable data on this disease is often gathered from informally asking owners for their observations of their pet's behaviour. The difficulty until now has been knowing how to reliably record this valuable information so that it can recalled the next time the patient visits."
The new tool, which takes the form of a questionnaire, attaches score rates to quantify the level of disease against key questions addressed to the dog's owner. Owners are asked to grade their dog's activity and exercise levels, stiffness and lameness, and any changes that occur in different weather conditions. The information is recorded digitally so that it can be referred to throughout a patient's treatment programme.
Ben said: "This record of behaviour history, together with clinical assessment, could provide a more detailed understanding of how the disease is progressing, and importantly how healthy and comfortable the dog is."
Research which validates the new tool has been published on PLOS ONE here.
The Puppy Contract was launched in 2012 to help prospective buyers navigate the steps leading up to the purchase of a new puppy. It includes a ten-step guide which considers things like which type of dog is most suited to a buyer’s situation and specific needs, and the questions to ask a breeder about socialisation, vaccination, microchipping and health tests.
The latest BVA Voice of the Veterinary Profession survey shows that while awareness of The Puppy Contract among companion animal vets has almost doubled since 2015 (from 29% to 56%), it is thought that no more than 2.5% of clients are actually using it.
Nevertheless, 85% of vets said using The Puppy Contract benefits and informs owners, and 20% recommend it to clients at least sometimes.
Half of the vets who were aware of The Puppy Contract said that pet owners did not come to them for advice on buying a puppy. That's a missed opportunity, both to start building a relationship with the prospective client at the earliest opportunity and to recommend the contract and thereby have a positive impact on animal welfare.
As regards the latter, it is worth noting some other BVA stats, notably that 10% of vets said they commonly saw dogs last year with health issues linked to where they were bought from, nearly a third noted brachycephalic issues or other congenital and conformation problems stemming from poor purchasing decisions and 22% saw dogs not suited to their environment.
BVA Junior Vice President and AWF Trustee Daniella Dos Santos said: "As vets, we see first-hand the tragic consequences resulting from puppies bought without proper research into breed suitability and welfare needs, the conditions they have been bred in, or vaccination and microchipping records. As a result, many of these puppies often present with disease, welfare issues and behavioural problems, leading to heartache and financial costs for the new owners.
"It’s extremely encouraging to see that more than half of companion animal vets are now aware of The Puppy Contract and recognise its immense benefits. But with many pet owners still not aware that their vet can be an invaluable first stop for advice on the right pet for them, it’s important that we promote pre-purchase consultations to ensure prospective owners make an informed choice and get a healthy, happy and well-socialised pet from a responsible breeder."
AWF Chair of Trustees Chris Laurence said: "We believe that every dog should be born with the best possible chance of living a healthy and happy life, which is why we created The Puppy Contract as a free tool to empower puppy buyers to make an informed decision when buying a puppy. As trusted experts, vets are in a unique position to use their influence to encourage clients to use The Puppy Contract, whether they are breeding dogs or looking for a new best friend to join the family."
For more information and to download the Puppy Contract, see: https://puppycontract.org.uk/
You can download and display AWF’s Puppy Contract poster in your practice: www.animalwelfarefoundation.org.uk/puppy-contract.
Achieved by VMG members who have demonstrated an ability to effectively manage a veterinary practice, hospital or unit, the CVPM is aimed at experienced managers and members of the veterinary team in a leadership or management role. The qualification tests the knowledge of candidates in areas including management, HR, communication, marketing and financial planning.
VMG Director Georgina Hills (pictured right) said: "Effective veterinary leaders require expertise in all aspects of running a successful business, as well as a deep understanding of the veterinary sector and the CVPM is unique in testing their knowledge across the board. It is increasingly recognised as a benchmark for excellence and we are delighted to have seen an uplift in applications last year."
Further details on the CVPM and the application form are available here: https://www.vetmg.com/education/cvpm/
Apoquel chewable tablets were approved by the Veterinary Medicines Directorate (VMD) in November 2021.
Apoquel Chewable contains the same active ingredient, at the same dosing regime, for the same indications as original Apoquel, but in a palatable formulation which, in a field-study of client-owned dogs, was found to have a 91.6% acceptance rate.1
Dr Carly Mason, President of the British Veterinary Dermatology Study Group (BVDSG), said: “The new chewable form of Apoquel provides owners with a means of controlling itch using a tablet that can be given like a treat or mixed with a meal, making it much easier for owners and more acceptable to their pet.
“In many cases, the chewable formulation will be the obvious first-line Apoquel for veterinarians to prescribe to control canine itching while the underlying cause of allergic dermatitis is investigated.”
Reference
The study “Evaluation of quick sequential organ failure scores in dogs with severe sepsis and septic shock1” reviewed electronic records from dogs that presented through the veterinary medical teaching hospital emergency service between January 2010 and December 2019 using the search terms “sepsis” or “septic”.
The quick sequential organ failure score was calculated by evaluating respiratory rate (>22 breaths per minute), arterial systolic blood pressure (≤100mmHg) and altered mentation.
Forty-five dogs with severe sepsis and septic shock and 45 dogs with non-infectious systemic inflammatory response syndrome were included in the final analysis.
It was found that the quick sequential organ failure assessment score provided poor discrimination between survivors and non-survivors for dogs with severe sepsis and septic shock.
In addition, the quick sequential organ failure score demonstrated a poor sensitivity and fair specificity to detect this population of canine patients.
The authors say that previous studies on quick sequential organ failure score have provided conflicting results, but that this may just be due to the inherent heterogeneity of the population.
Considering the results of this study, it may not be possible to identify a single scoring system that serves the purpose that quick sequential organ failure assessment is intended for.
Nicola Di Girolamo, Editor of the JSAP said: “The results of this study have strong clinical implications.
"The JSAP values studies with negative findings such as this one, as much as studies with positive findings.
"The fact that a diagnostic tool or a treatment does not reach the desired objective, should not hinder publication of methodologically sound research”
https://onlinelibrary.wiley.com/doi/pdf/10.1111/jsap.13522
Mr Antonovs faced three charges.
The first was that in September 2020 whilst in practice at Beverley Vets4Pets, he attended work when under the influence of alcohol.
The second was that between September and December 2020, whilst at Peel Veterinary Clinic, he attended work on two occasions when under the influence of alcohol.
The final charge was that between February 2021 and February 2023, Mr Antonovs failed to respond adequately to requests from the RCVS regarding concerns raised about his conduct and/or health.
Mr Antonovs admitted the facts of the charges and the Committee decided that the facts amounted to serious professional misconduct.
The Committee therefore decided, in the particular circumstances of this case, to impose a reprimand and warning as to his future conduct on the basis that it would be proportionate in order to maintain public confidence in the profession and uphold proper standards of conduct and behaviour.
The full details of the hearing and the Committee’s decision can be found at www.rcvs.org.uk/disciplinary
In 2014 ioLight co-founders, Oxford physicists Andrew Monk and Richard Williams, filed a patent application for a pocket-sized digital microscope with a performance that compares with expensive laboratory microscopes. They asked Cambridge Industrial Design to realise the product, briefing them that the device would need to deliver images with one micron resolution (required to view human or animal cells) onto a smartphone or tablet, be pocket-sized, easy to use, and economical to build in medium to high volumes.
One of the biggest challenges was in making the unit pocket-sized, which meant it had to be foldable, something which could have led to a loss in the rigidity needed to achieve high resolution images. This challenge was overcome with the use of a single hinge which the company says makes the ioLight both portable and robust.
Alex Jones, Managing director of Cambridge Industrial Design said: "We recognised immediately this was a great idea but the design brief was certainly a challenge. Fortunately, challenges can sometimes bring out the best in designers. The final design is a real success both aesthetically and ergonomically, and this award is a fantastic acknowledgement for the design process and the final product that we have created together with ioLight."
ioLight is also celebrating another success: closing its second round of equity funding after raising £320k from 335 investors on the Crowdcube platform (128% of the initial target).
The company says the new funding will allow it to promote the microscope to a wide range of target markets including veterinary surgeons, education, laboratory and field research, museums and public engagement as well as to international markets.
Andrew Monk, ioLight’s co-founder said: "The product is so simple to use that it is the ideal communication tool for explaining science to the public, students and customers. The microscope lets everyone see the same image so the discussion is about the picture not the tools. It’s a perfect fit for government public engagement campaigns, which are well funded at the moment. We are absolutely delighted that this funding provides us with the opportunity for both product development and to reach out and make microscopy available to so many more people."
The new leaflet, ‘Separation anxiety as a result of the pandemic. What can you do?’, was written in collaboration with clinical animal behaviourist, Rosie Bescoby, and is aimed at dog owners whose pets are struggling to adjust to the ‘new normal’.
It includes an overview of separation anxiety, including the signs to look out for and how to tackle it, together with training tips to help adult dogs and preventative advice for puppies.
The leaflet also includes advice on the dog fear ladder, which demonstrates the different levels of fear a dog may exhibit resulting in more extreme reactions being displayed, and information on the Adaptil range of products which help support dogs throughout their lives.
The leaflet is available as both a printed and online version to enable vet practices to distribute it to their clients in a format of their choice. It is supported by a social media toolkit for vet practices consisting of posts, graphics and a video.
Abigail King, senior behaviour product manager at Ceva Animal Health, said: “Lockdowns have been a positive experience for many of our dogs, as they are social animals and love being with their owners.
“However, with the 2021 PFMA annual pet population report confirming that 3.2 million households in the UK have acquired a pet since the start of the pandemic, some pet owners have never left their dogs home alone, so it’s going to be a totally new experience which some pets may struggle with.
"Our new separation anxiety leaflet will help support both pets and owners as they adjust to the new normal.”
For further information, contact your local Ceva Animal Health account manager or email cevauk@ceva.com.
Carl's article: 'Are you using a safety checklist in your practice?', focuses on the benefits of introducing a safety checklist in practice to reduce patient morbidity, mortality and to improve communication between members of the veterinary team.
He explains how a checklist helps eliminate the need to memorise every single step of a protocol and self-limit any errors that may eventually lead to a fatal or near-fatal incident, and how it should contain a limited number of elements, allow quick completion and most importantly be relevant to the situation.
The article includes information on how to introduce a safety checklist, steps to consider and how to use one in practice.
It also contains links to downloadable tools including the Association of Veterinary Anaesthetists (AVA) safety checklist and implementation booklet and information on the association’s ‘Safer Anaesthesia Project’. An editable safety checklist will also be available to download from the ‘Anaesthesia1ST’ blog that practices can adapt to their own requirements.
Richard Beckwith, country manager of Jurox (UK) said: "Our hugely popular Anaesthesia1ST newsletter features state-of-the-art, practical and easy to read articles to help veterinary professionals deliver 1ST class anaesthesia to all patients. Our latest edition will challenge practices to consider safety checklists as an essential part of their pre-anaesthetic routine in order to reduce the risk of mistakes."
To sign up to the Anaesthesia1ST newsletter visit the Alfaxan website – www.alfaxan.co.uk, contact your local Jurox technical sales representative or email Jurox at info@jurox.co.uk.
The BVA, the Mayhew Animal Hospital, Dogs Today magazine and the Kennel Club are amongst various organisations that have criticised Morrisons for its Christmas advert - which can be seen here - in which a child is seen passing a slice of Christmas pudding to the family dog.
BVA President Peter Jones said: "It is vital that advertisers use animals responsibly and we are disappointed to see the Morrisons Christmas desserts TV commercial depicting a small boy feeding Christmas pudding to his dog. Christmas pudding, Christmas cake and mince pies - because they contain raisins or sultanas - are potentially harmful to pets and in some cases can lead to kidney failure.
"While we accept that many pet owners understand what is and what is not appropriate to feed their pets, children watch adverts and can be easily influenced by what they see. Veterinary organisations and animal welfare charities work really hard to promote messages about responsible pet ownership and TV adverts such as this one, with huge audiences, can undermine this work."
But hang on a second. Watching the advert, the child isn't actually feeding the dog anything. Rather, the dog is passed a bit of pudding which it then goes and places in a flowerpot, causing the plant to wilt. The dog isn't being fed the stuff, it's being asked to get rid of it.
Surely what this advert is really saying is: nobody likes Christmas pudding, least of all children and dogs.
Mind you, it does look like all this fuss is proving a very effective public awareness campaign about the danger of feeding a dog raisins or sultanas.
The extension includes a new diagnostic imaging suite with both CT and MRI scanners, a fourth operating theatre, two more consulting rooms, an additional ward for dogs and an expanded office for clinicians.
North Downs hospital director Terry Emmerson said: "This significant investment illustrates our commitment to providing the highest standards of medical and surgical care for our pets in a caring, compassionate environment.
"It has provided us with a number of important new facilities, allowing us to continue to build on our services and our level of care.
As part of the expansion, North Downs has also recruited five more clinicians, two specialising in small animal surgery, one in neurology, one in ophthalmology and one in anaesthesia.
Mr Emmerson said: "All the investment in facilities and technology is very important and exciting but we also recognised the need to invest in recruiting more talented staff to help us make the most of it all.
"That’s why we have added five new clinicians in several key disciplines and in turn increased the size of our clinicians’ office to help incorporate those additional staff.
"It all means we can now offer an even better service, leading facilities and treatment within a far more structured and organised layout which helps makes everything more efficient and user-friendly for staff and patients."
For more information about North Downs Specialist Referrals, visit www.ndsr.co.uk.
The study analysed information from a random sample of 29,865 dogs that died over a one-year period, taken from a study population of 905,544 dogs from 626 clinics in the VetCompass database.
From the sample, 26,676 (91.5%) of deaths recorded in practice involved euthanasia and 2,487 (8.5%) of deaths were unassisted. However, it is unknown how many dogs die unassisted and unreported to a practice.
Perhaps unsurprisingly, the findings indicated that certain types of diseases and conditions were more likely to lead to death by euthanasia than unassisted death.
by contrast,
Larger bodyweights, increasing age and certain breeds of dog were also additional risk factors for euthanasia. Rottweilers were more likely to die by euthanasia compared to Labrador Retrievers as the standard baseline breed. In contrast, breeds such as Bulldogs, Pugs and West Highland White Terriers were more likely to have unassisted deaths, and these deaths were more likely caused by traumatic injury, foreign body and heart disease.
Additional findings from the study included:
Camilla Pegram, VetCompass Epidemiologist at the RVC, and author of the paper, said: “End-of-life discussions between veterinarians and owners can be particularly difficult for both parties. This study provides benchmark data for the relative proportion of deaths that involve euthanasia and for the relative impact from demographics and disorders on euthanasia decision-making. Owners and veterinary professionals may find it easier to discuss end-of-life options, to reach a final decision and be comfortable with these decisions based on a feeling of broader support from the reported actions of others in similar situations.”
Dr Dan O’Neill, Senior Lecturer, Companion Animal Epidemiology, at the RVC, and co-author of the paper, said: "The decision for many animal owners to put a beloved dog to sleep is often the hardest decision of their life. The moment of euthanasia often lives with owners forever. Hopefully, the information from this study can at least help some owners come to terms with the responsibility of helping their dog go with dignity. Understanding that over 90% of other owners also opted for euthanasia may help anyone struggling to make this final and hardest decision.”
Dr Carol Gray, Research Associate at the University of Liverpool and co-author of the paper, said: "Decision-making around euthanasia is shared between veterinarian and owner, although it is the owner who must give consent for euthanasia. Providing this final authorisation is potentially a burden for owners. This paper will help to ease that burden by allowing veterinarians to provide reassurance that they are not the only dog owners to make a decision for euthanasia in similar circumstances.”
Pegram, C., Gray, C., Packer, R.M.A. et al. Proportion and risk factors for death by euthanasia in dogs in the UK. Sci Rep 11, 9145 (2021). https://doi.org/10.1038/s41598-021-88342-0
Pfizer has divested itself of its animal health business unit, which has become a stand-alone company called Zoetis. The new company unveiled its vision for Europe, Africa and the Middle East (EuAfME) region at a press conference in Paris last week.
The company says it aims to have its products, services and people as the most valued by animal health customers around the region, and the world.
Alejandro Bernal, Zoetis Executive Vice President and Area President for the EuAfME region said: "We are united around this shared vision, and we strive every day to help customers meet their real-world challenges through quality medicines and vaccines, complemented by diagnostic products, genetic tests and a range of services," said "As the largest standalone company in the industry, we are dedicated solely to animal health and focusing on our core business so our customers can grow theirs."
In addition to working closely with customers, Zoetis said it strives to collaborate with universities and other research organisations, to help advance the animal health sector and those who raise and care for animals. One example of this is the partnership with the University of Stirling, one of the leading research organisations, based in Scotland.
Professor Randolph Richards, from Stirling said: "Academia is increasingly realising the benefits of working with industry on research projects, and is concentrating on those with more direct impact rather than on pure research. In our own case, Zoetis has been able to provide resources which were otherwise unavailable to us, with funding opportunity being provided through the UK Technology Strategy Board."